期刊
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
卷 25, 期 24, 页码 11333-11337出版社
WILEY
DOI: 10.1111/jcmm.17019
关键词
berberine; inflammation; periodontitis
Accumulated evidence suggests that berberine (BBR), a bioactive alkaloid compound isolated from Coptidis rhizoma, has potential anti-inflammatory properties in controlling or treating inflammatory diseases, including periodontitis. Studies have shown that BBR can reduce the expression and secretion of pro-inflammatory mediators, making it a promising treatment option for periodontitis and other inflammatory diseases.
Accumulating evidence during the last two decades has addressed the potential anti-inflammatory properties of berberine (BBR), a bioactive alkaloid compound isolated from Coptidis rhizoma, in controlling or treating several inflammatory diseases. Periodontitis is one of the most common chronic and serious inflammatory diseases, in which uncontrolled and unabated host immune responses against periodontopathic pathogens play critical and crucial roles in the disease pathogenesis. Hence, regulating inflammatory responses in periodontitis has a valuable approach and holds promise in treating periodontitis. For the first time, this paper reviews the evidence from in vitro and in vivo experimental models to explore the anti-inflammatory effects of BBR in periodontitis and exhibits that BBR has the high potency to exert anti-inflammatory effects by reducing expression and secretion of pro-inflammatory mediators including TNF-alpha, IL-1 beta, IL-17, RANKL, MMP-2, MMP-9 and MCP-1. The BBR-mediated anti-inflammatory actions could translate into the inhibition of the periodontal tissues and alveolar bone destruction and the control of the disease in vivo. As the second aim of this paper, we also paid attention to the therapeutic potential of BBR in treating human diseases regarding its anti-inflammatory properties.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据